Kate Madden Yee is a journalist at AuntMinnie.com. With a focus on medical imaging, particularly MRI and CT, she has been exploring the intersection of healthcare technology and patient care since 1998. Kate's work has been featured in LabPulse and Cook Medical Australia, highlighting her expertise in digital health and telehealth within the broader themes of medicine and healthcare.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Kate Madden Yee's articles focus predominantly on medical imaging, particularly MRI and CT scans, with an emphasis on how these technologies are used in cancer diagnosis and other medical conditions. Her coverage heavily relies on data citations.
If reaching out to Kate, consider offering insights or data-driven information related to advancements or new research findings in the field of medical imaging, especially concerning MRI and CT scans as they pertain to cancer diagnosis and treatment. Additionally, experts who can provide detailed analysis based on empirical evidence would likely resonate well with her coverage style.
Since Kate’s geographic focus is not specified but she covers scientific topics widely applicable across regions, pitches should emphasize universal relevance rather than regional specificity.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Kate Madden Yee
SNMMI: New brain imaging agent tracks progressive supranuclear palsy
Research findings could improve the experience of patients undergoing these exams as well as the quality of the imaging itself.
By: Kate Madden Yee
An alpha-emitting radiotracer produced remission in patients who had exhausted typical treatment options for neuroendocrine tumors.
Study findings suggest "a clinical role for PET in traumatic brain injury and sports- and military-related neurodegeneration."
By: Kate Madden Yee
An alpha-emitting radiotracer produced remission in patients who had exhausted typical treatment options for neuroendocrine tumors.
By: Kate Madden Yee
An alpha-emitting radiotracer produced remission in patients who had exhausted typical treatment options for neuroendocrine tumors.
By: Kate Madden Yee
The findings "support the use of brain-dedicated PET scanners as a patient-centered alternative," researchers wrote.
By: Kate Madden Yee
An increase in the use of radionuclide therapy has added burden to wastewater management systems.
By: Kate Madden Yee
Metabolic status should be considered in post-therapy evaluation of obese differentiated thyroid cancer patients, researchers noted.
By: Kate Madden Yee
The approach has the potential to reshape surgical practice for osteosarcoma by allowing for precise tumor resection.
